Effect of aerobic training on the host systemic milieu in patients with solid tumours: an exploratory correlative study

[1]  Jason D. Allen,et al.  Modulation of Circulating Angiogenic Factors and Tumor Biology by Aerobic Training in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy , 2013, Cancer Prevention Research.

[2]  M. Barcellos-Hoff,et al.  The evolution of the cancer niche during multistage carcinogenesis , 2013, Nature Reviews Cancer.

[3]  M. Dewhirst,et al.  Effects and potential mechanisms of exercise training on cancer progression: A translational perspective , 2013, Brain, Behavior, and Immunity.

[4]  L. Jones,et al.  Exercise-oncology research: Past, present, and future , 2013, Acta oncologica.

[5]  M. Irwin,et al.  Effect of Exercise on Markers of Inflammation in Breast Cancer Survivors: The Yale Exercise and Survivorship Study , 2012, Cancer Prevention Research.

[6]  S. Blair,et al.  Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy , 2012, BDJ.

[7]  T. Golub,et al.  Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion , 2012, Nature.

[8]  Sameer M. Siddiqi,et al.  Physical activity, biomarkers, and disease outcomes in cancer survivors: a systematic review. , 2012, Journal of the National Cancer Institute.

[9]  W. Kraus,et al.  Baseline metabolomic profiles predict cardiovascular events in patients at risk for coronary artery disease. , 2012, American heart journal.

[10]  P. Goodwin,et al.  Insulin- and obesity-related variables in early-stage breast cancer: correlations and time course of prognostic associations. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  George Coukos,et al.  Cancer immunotherapy comes of age , 2011, Nature.

[12]  Bernard Henrissat,et al.  The Impact of a Consortium of Fermented Milk Strains on the Gut Microbiome of Gnotobiotic Mice and Monozygotic Twins , 2011, Science Translational Medicine.

[13]  Daniel Umpierre,et al.  Physical activity advice only or structured exercise training and association with HbA1c levels in type 2 diabetes: a systematic review and meta-analysis. , 2011, JAMA.

[14]  L. Jones,et al.  Effect of exercise training on peak oxygen consumption in patients with cancer: a meta-analysis. , 2011, The oncologist.

[15]  N. Berger,et al.  Energy balance, host-related factors, and cancer progression. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  R. Weinberg,et al.  Tumor-host interactions: a far-reaching relationship. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  S. Carr,et al.  Metabolic Signatures of Exercise in Human Plasma , 2010, Science Translational Medicine.

[18]  R. Speck,et al.  An update of controlled physical activity trials in cancer survivors: a systematic review and meta-analysis , 2010, Journal of cancer survivorship : research and practice.

[19]  M. Joyner,et al.  Exercise protects the cardiovascular system: effects beyond traditional risk factors , 2009, The Journal of physiology.

[20]  Yasuo Ohashi,et al.  Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis. , 2009, JAMA.

[21]  K. Courneya,et al.  Effects of aerobic exercise training in anemic cancer patients receiving darbepoetin alfa: a randomized controlled trial. , 2008, The oncologist.

[22]  R. Weinberg,et al.  Systemic Endocrine Instigation of Indolent Tumor Growth Requires Osteopontin , 2008, Cell.

[23]  Wan-Wan Lin,et al.  A cytokine-mediated link between innate immunity, inflammation, and cancer. , 2007, The Journal of clinical investigation.

[24]  F. Farrell,et al.  Recombinant epoetins do not stimulate tumor growth in erythropoietin receptor–positive breast carcinoma models , 2006, Molecular Cancer Therapeutics.

[25]  K. Courneya,et al.  Randomized controlled trial of exercise and blood immune function in postmenopausal breast cancer survivors. , 2005, Journal of applied physiology.

[26]  S. Sheen-Chen,et al.  Serum Levels of Hepatocyte Growth Factor in Patients with Breast Cancer , 2005, Cancer Epidemiology Biomarkers & Prevention.

[27]  S. Sheen-Chen,et al.  Serum concentration of tumor necrosis factor in patients with breast cancer , 1997, Breast Cancer Research and Treatment.

[28]  G. Forni,et al.  Death Receptor Ligands in Tumors , 2002, Journal of immunotherapy.

[29]  Guo‐Jun Zhang,et al.  Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma. , 1999, Anticancer research.